{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:27:27Z","timestamp":1783114047439,"version":"3.54.6"},"reference-count":92,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002894","name":"American Academy of Allergy Asthma and Immunology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002894","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08 AI148456"],"award-info":[{"award-number":["K08 AI148456"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jaip.2022.09.022","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:23:32Z","timestamp":1663939412000},"page":"3117-3123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Proton Pump Inhibitors in Allergy: Benefits and Risks"],"prefix":"10.1016","volume":"10","author":[{"given":"Lacey B.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie A.","family":"Ruffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.09.022_bib1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2022.09.022_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0163-7258(03)00015-9","article-title":"Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future","volume":"98","author":"Aihara","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaip.2022.09.022_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jhm.2064","article-title":"Choosing wisely in pediatric hospital medicine: five opportunities for improved healthcare value","volume":"8","author":"Quinonez","year":"2013","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.jaip.2022.09.022_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.gtc.2016.02.005","article-title":"Gastrointestinal diseases in pregnancy: nausea, vomiting, hyperemesis gravidarum, gastroesophageal reflux disease, constipation, and diarrhea","volume":"45","author":"Body","year":"2016","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaip.2022.09.022_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.09.022_bib6","doi-asserted-by":"crossref","first-page":"m3786","DOI":"10.1136\/bmj.m3786","article-title":"Advances in the diagnosis and management of gastroesophageal reflux disease","volume":"371","author":"Katzka","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2022.09.022_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","article-title":"Complications of proton pump inhibitor therapy","volume":"153","author":"Vaezi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.09.022_bib8","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2021.12.247","article-title":"AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review","volume":"162","author":"Targownik","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.09.022_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169300","article-title":"Histamine H2-blocker and proton pump inhibitor use and the risk of pneumonia in acute stroke: a retrospective analysis on susceptible patients","volume":"12","author":"Arai","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2022.09.022_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1378\/chest.129.1_suppl.80S","article-title":"Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines","volume":"129","author":"Irwin","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2022.09.022_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1378\/chest.15-1496","article-title":"Treatment of unexplained chronic cough: CHEST guideline and expert panel report","volume":"149","author":"Gibson","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2022.09.022_bib12","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1378\/chest.103.6.1662","article-title":"Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol","volume":"103","author":"Irwin","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2022.09.022_bib13","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/BF02090360","article-title":"Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study","volume":"39","author":"Meier","year":"1994","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaip.2022.09.022_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0002-9343(97)89514-9","article-title":"Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome","volume":"100","author":"Harding","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2022.09.022_bib15","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1164\/rccm.200507-1167OC","article-title":"Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial","volume":"173","author":"Kiljander","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 3A","key":"10.1016\/j.jaip.2022.09.022_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(03)00196-7","article-title":"The role of proton pump inhibitors in the management of gastroesophageal reflux disease-related asthma and chronic cough","volume":"115","author":"Kiljander","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2022.09.022_bib17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1378\/chest.116.5.1257","article-title":"Gastroesophageal reflux in asthmatics: a double-blind, placebo-controlled crossover study with omeprazole","volume":"116","author":"Kiljander","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2022.09.022_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa0806290","article-title":"Efficacy of esomeprazole for treatment of poorly controlled asthma","volume":"360","author":"Mastronarde","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.09.022_bib19","first-page":"CD001496","article-title":"Pharmacological and surgical interventions for the treatment of gastro-oesophageal reflux in adults and children with asthma","volume":"5","author":"Kopsaftis","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2022.09.022_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043860","article-title":"Randomised trials of proton pump inhibitors for gastro-oesophageal reflux disease in patients with asthma: an updated systematic review and meta-analysis","volume":"11","author":"Zheng","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2022.09.022_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02730-2021","article-title":"Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes","volume":"59","author":"Reddel","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2022.09.022_bib22","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"2020 Focused Updates to the Asthma Management Guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group","volume":"146","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib23","article-title":"Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation: the PEPTIC randomized clinical trial","volume":"323","author":"Young","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2022.09.022_bib24","doi-asserted-by":"crossref","first-page":"l6722","DOI":"10.1136\/bmj.l6722","article-title":"Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline","volume":"368","author":"Ye","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2022.09.022_bib25","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-054527","article-title":"Stress ulcer prophylaxis for critical asthma","volume":"149","author":"Roberts","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2022.09.022_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1358863X18815971","article-title":"Missed opportunities to prevent upper GI hemorrhage: the experience of the Michigan Anticoagulation Quality Improvement Initiative","volume":"24","author":"Kurlander","year":"2019","journal-title":"Vasc Med Lond Engl"},{"key":"10.1016\/j.jaip.2022.09.022_bib27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.14309\/ajg.0000000000000558","article-title":"Physicians\u2019 perceptions of proton pump inhibitor risks and recommendations to discontinue: a national survey","volume":"115","author":"Kurlander","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2022.09.022_bib28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1053\/j.gastro.2016.08.054","article-title":"Association of proton pump inhibitors with reduced risk of warfarin-related serious upper gastrointestinal bleeding","volume":"151","author":"Ray","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.09.022_bib29","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE Conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.09.022_bib30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2050640616689525","article-title":"Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults","volume":"5","author":"Lucendo","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jaip.2022.09.022_bib31","author":"Centers for Medicare & Medicaid Services"},{"key":"10.1016\/j.jaip.2022.09.022_bib32","author":"Centers for Medicare & Medicaid Services"},{"key":"10.1016\/j.jaip.2022.09.022_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cgh.2015.07.041","article-title":"Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis","volume":"14","author":"Lucendo","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2022.09.022_bib34","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1053\/j.gastro.2020.02.039","article-title":"Technical review on the management of eosinophilic esophagitis: a report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters","volume":"158","author":"Rank","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.09.022_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2147\/JAA.S274524","article-title":"Proton pump inhibitor therapy for eosinophilic esophagitis: history, mechanisms, efficacy, and future directions","volume":"15","author":"Franciosi","year":"2022","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2022.09.022_bib36","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1053\/j.gastro.2020.02.038","article-title":"AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters clinical guidelines for the management of eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.09.022_bib37","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.dld.2022.03.006","article-title":"Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis","volume":"54","author":"Thakkar","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaip.2022.09.022_bib38","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ajg.2015.314","article-title":"Long-term loss of response in proton pump inhibitor-responsive esophageal eosinophilia is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis","volume":"110","author":"Molina-Infante","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2022.09.022_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MPG.0000000000002480","article-title":"CYP2C19 and STAT6 variants influence the outcome of proton pump inhibitor therapy in pediatric eosinophilic esophagitis","volume":"69","author":"Mougey","year":"2019","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2022.09.022_bib40","first-page":"CD002095","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","author":"Sigterman","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2022.09.022_bib41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archinternmed.2010.94","article-title":"Proton pump inhibitor use, hip fracture and change in bone density in postmenopausal women results from the Women\u2019s Health Initiative","volume":"170","author":"Gray","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2022.09.022_bib42","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ajg.2012.200","article-title":"The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based from the Canadian Multicentre Osteoporosis Study (CaMos)","volume":"107","author":"Targownik","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2022.09.022_bib43","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.gastro.2009.11.014","article-title":"Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss","volume":"138","author":"Targownik","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.09.022_bib45","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","article-title":"Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.09.022_bib46","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","article-title":"Systematic review of the risk of enteric infection in patients taking acid suppression","volume":"102","author":"Leonard","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2022.09.022_bib47","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/IAI.01138-07","article-title":"Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens","volume":"76","author":"Tennant","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaip.2022.09.022_bib48","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10620-017-4905-3","article-title":"Proton pump inhibitors increase the susceptibility of mice to oral infection with enteropathogenic bacteria","volume":"63","author":"Yasutomi","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaip.2022.09.022_bib49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","article-title":"Biopsy-proven acute interstitial nephritis, 1993-2011","volume":"64","author":"Muriithi","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaip.2022.09.022_bib50","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.ajkd.2019.07.012","article-title":"Proton pump inhibitors and the kidney: implications of current evidence for clinical practice and when and how to deprescribe","volume":"75","author":"Al-Aly","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaip.2022.09.022_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/idoj.idoj_237_21","article-title":"Proton pump inhibitor induced subacute cutaneous lupus erythematosus: a case series of 7 patients and brief review of literature","volume":"13","author":"Kaur","year":"2022","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaip.2022.09.022_bib52","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1177\/09612033221104237","article-title":"Proton pump inhibitor induced subacute cutaneous lupus erythematosus: clinical characteristics and outcomes","volume":"31","author":"Poh","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.jaip.2022.09.022_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40264-016-0473-2","article-title":"Proton pump inhibitors and risk of rhabdomyolysis","volume":"40","author":"Duncan","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2022.09.022_bib54","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s40264-017-0564-8","article-title":"Muscular adverse drug reactions associated with proton pump inhibitors: a disproportionality analysis using the Italian National Network of Pharmacovigilance Database","volume":"40","author":"Capogrosso Sansone","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2022.09.022_bib55","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-151-10-200911170-00016","article-title":"Hypomagnesemia induced by several proton-pump inhibitors","volume":"151","author":"Broeren","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2022.09.022_bib56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2009.11.019","article-title":"A\u00a0case series of proton pump inhibitor\u2013induced hypomagnesemia","volume":"56","author":"Hoorn","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaip.2022.09.022_bib57","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.ajkd.2013.02.373","article-title":"Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study","volume":"62","author":"Koulouridis","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaip.2022.09.022_bib58","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7150\/ijms.4397","article-title":"Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System","volume":"9","author":"Tamura","year":"2012","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jaip.2022.09.022_bib59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fphar.2018.00363","article-title":"Proton pump inhibitors and serum magnesium levels in patients with torsades de pointes","volume":"9","author":"Lazzerini","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2022.09.022_bib60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/14779072.2019.1615446","article-title":"Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias","volume":"17","author":"Chrysant","year":"2019","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jaip.2022.09.022_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40801-021-00234-x","article-title":"Drug-associated QTc prolongation in geriatric hospitalized patients: a cross-sectional study in internal medicine","volume":"8","author":"Rossi","year":"2021","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.jaip.2022.09.022_bib62","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00228-011-1119-z","article-title":"Lansoprazole precipitated QT prolongation and torsade de pointes associated with disopyramide","volume":"68","author":"Asajima","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2022.09.022_bib63","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1161\/CIRCEP.112.000101","article-title":"Pantoprazole (proton pump inhibitor) contributing to torsades de pointes storm","volume":"6","author":"Bibawy","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jaip.2022.09.022_bib64","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/jocd.13763","article-title":"Dermatologic adverse reactions to proton-pump inhibitors: a synthetized review","volume":"20","author":"Salloum","year":"2021","journal-title":"J\u00a0Cosmet Dermatol"},{"key":"10.1016\/j.jaip.2022.09.022_bib65","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/all.13235","article-title":"Delayed-type hypersensitivity reactions induced by proton pump inhibitors: a clinical and in\u00a0vitro T-cell reactivity study","volume":"73","author":"Lin","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.022_bib66","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.2500\/aap.2020.41.190033","article-title":"Hypersensitivity reactions to proton-pump inhibitors: clinical presentation, diagnosis, and management","volume":"41","author":"Kepil \u00d6zdemir","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2022.09.022_bib67","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1345\/aph.19235","article-title":"Anaphylactic reactions to proton-pump inhibitors","volume":"34","author":"Natsch","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaip.2022.09.022_bib68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000493581","article-title":"Immediate-type hypersensitivity cross-reactions to proton pump inhibitors: a descriptive study of data from the French National Pharmacovigilance Database","volume":"178","author":"Tourillon","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib69","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaci.2012.04.048","article-title":"Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test","volume":"130","author":"Bonadonna","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib70","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/all.12189","article-title":"Immediate-type hypersensitivity reactions to proton pump inhibitors: usefulness of skin tests in the diagnosis and assessment of cross-reactivity","volume":"68","author":"Kepil \u00d6zdemir","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.022_bib71","first-page":"157","article-title":"Study of cross-reactivity between proton pump inhibitors","volume":"20","author":"Sobrevia Elfau","year":"2010","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib72","first-page":"140","article-title":"Allergy to proton pump inhibitors: diagnosis and assessment of cross-reactivity","volume":"18","author":"Garrido Fern\u00e1ndez","year":"2008","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib73","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1398-9995.2005.00765.x","article-title":"Allergy to lansoprazole: study of cross-reactivity among proton-pump inhibitors","volume":"60","author":"Porcel","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.022_bib74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11882-016-0595-8","article-title":"Immediate and delayed hypersensitivity reactions to proton pump inhibitors: evaluation and management","volume":"16","author":"Otani","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.09.022_bib75","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jaci.2005.11.001","article-title":"Hypersensitivity to lansoprazole and rabeprazole with tolerance to other proton pump inhibitors","volume":"117","author":"P\u00e9rez Pimiento","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib76","doi-asserted-by":"crossref","first-page":"eaau6753","DOI":"10.1126\/scitranslmed.aau6753","article-title":"Inactive\u201d ingredients in oral medications","volume":"11","author":"Reker","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2022.09.022_bib77","unstructured":"National Library of Medicine\u2019s DailyMed searchable database. Available from: dailymed.nlm.nih.gov. Accessed August 9, 2022."},{"key":"10.1016\/j.jaip.2022.09.022_bib78","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaip.2012.09.004","article-title":"Near fatal anaphylaxis from orally administered gelatin capsule","volume":"1","author":"Land","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.022_bib79","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nri.2017.39","article-title":"Early life factors that affect allergy development","volume":"17","author":"Reynolds","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib83","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.jaci.2016.09.046","article-title":"Acid-suppressive medications during pregnancy and risk of asthma and allergy in children: a systematic review and meta-analysis","volume":"139","author":"Devine","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib82","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-0889","article-title":"Acid-suppressive drug use during pregnancy and the risk of childhood asthma: a meta-analysis","volume":"141","author":"Lai","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2022.09.022_bib84","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2018.2513","article-title":"Association between use of acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood","volume":"172","author":"Mitre","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2022.09.022_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamapediatrics.2020.5710","article-title":"Association between proton pump inhibitor use and risk of asthma in children","volume":"175","author":"Wang","year":"2021","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2022.09.022_bib86","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2500\/aap.2013.34.3657","article-title":"Relationship between treatment with antacid medication and the prevalence of food allergy in children","volume":"34","author":"DeMuth","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2022.09.022_bib87","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaci.2017.05.018","article-title":"Prenatal, intrapartum, and postnatal factors are associated with pediatric eosinophilic esophagitis","volume":"141","author":"Jensen","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib80","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/1744666X.2018.1512405","article-title":"Acid suppressant medications and the risk of allergic diseases","volume":"14","author":"Robinson","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib81","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2222.2008.03125.x","article-title":"First evidence of a possible association between gastric acid suppression during pregnancy and childhood asthma: a population-based register study","volume":"39","author":"Dehlink","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.09.022_bib88","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0091-6749(03)01719-6","article-title":"Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB\/c mice","volume":"112","author":"Untersmayr","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib89","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1096\/fj.04-3170fje","article-title":"Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients","volume":"19","author":"Untersmayr","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.jaip.2022.09.022_bib90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/1744666X.2021.1874353","article-title":"The clinical implications of the microbiome in the development of allergy diseases","volume":"17","author":"Koidl","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib91","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2017.02.007","article-title":"The microbiome in allergic disease: current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology","volume":"139","author":"Huang","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.022_bib92","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jaip.2022.09.022_bib93","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jpeds.2014.12.067","article-title":"16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora","volume":"166","author":"Rosen","year":"2015","journal-title":"J\u00a0Pediatr"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822009588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822009588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:36:01Z","timestamp":1761975361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822009588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":92,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2213219822009588"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.09.022","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton Pump Inhibitors in Allergy: Benefits and Risks","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}